Liangzhang Sun

157 Xiwu Road
Xi'an, 710004, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

PPP4C restores YAP1 activity by modulating MST4 phosphorylation to enhance immunosuppression and augment tumor growth in non-small cell lung cancer.

PPP4C restores YAP1 activity by modulating MST4 phosphorylation to enhance immunosuppression and augment tumor growth in non-small cell lung cancer.

Journal: Cancer letters
Published: October 30, 2025

Retraction Note: RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma.

Retraction Note: RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma.

Journal: BMC cancer
Published: October 23, 2025

Knowledge, Attitudes, and Practices Among Thoracic Healthcare Professionals Toward Postoperative Pulmonary Embolism.

Knowledge, Attitudes, and Practices Among Thoracic Healthcare Professionals Toward Postoperative Pulmonary Embolism.

Journal: Healthcare (Basel, Switzerland)
Published: April 24, 2025

A novel mitochondrial metabolism-related gene signature for predicting the prognosis of oesophageal squamous cell carcinoma.

A novel mitochondrial metabolism-related gene signature for predicting the prognosis of oesophageal squamous cell carcinoma.

Journal: Aging
Published: October 27, 2023

Exosomal lncCRLA is predictive for the evolvement and development of lung adenocarcinoma.

Exosomal lncCRLA is predictive for the evolvement and development of lung adenocarcinoma.

Journal: Cancer letters
Published: August 25, 2023

Hsa-miR-1269a up-regulation fosters the malignant progression of esophageal squamous cell carcinoma via targeting FAM46C.

Hsa-miR-1269a up-regulation fosters the malignant progression of esophageal squamous cell carcinoma via targeting FAM46C.

Journal: Mutation research
Published: December 29, 2022

TMED3 exerts a protumor function in non-small cell lung cancer by enhancing the Wnt/β-catenin pathway via regulation of AKT.

TMED3 exerts a protumor function in non-small cell lung cancer by enhancing the Wnt/β-catenin pathway via regulation of AKT.

Journal: Toxicology and applied pharmacology
Published: August 16, 2021

lncCRLA Enhanced Chemoresistance in Lung Adenocarcinoma That Underwent EpithelialMesenchymal Transition.

lncCRLA Enhanced Chemoresistance in Lung Adenocarcinoma That Underwent EpithelialMesenchymal Transition.

Journal: Oncology research
Published: May 14, 2021

Circular RNA SMARCA5 suppressed non-small cell lung cancer progression by regulating miR-670-5p/RBM24 axis.

Circular RNA SMARCA5 suppressed non-small cell lung cancer progression by regulating miR-670-5p/RBM24 axis.

Journal: Acta biochimica et biophysica Sinica
Published: September 16, 2019

SphK1 promotes development of non‑small cell lung cancer through activation of STAT3.

SphK1 promotes development of non‑small cell lung cancer through activation of STAT3.

Journal: International journal of molecular medicine
Published: July 23, 2019

Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide.

Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide.

Journal: Pathology, research and practice
Published: June 21, 2019

RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma.

RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma.

Journal: BMC cancer
Published: December 27, 2018
Showing 1-12 of 19

Last Updated: 09/26/2026